Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,065 DKK | +1.98% | +3.10% | -4.18% |
04:14pm | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
02:28pm | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.18% | 18.97B | |
+7.47% | 111B | |
+11.23% | 106B | |
-12.50% | 22.24B | |
+0.44% | 21.25B | |
-37.85% | 18.52B | |
-8.79% | 16.81B | |
+37.25% | 12.54B | |
-24.35% | 8.09B | |
+316.39% | 7.99B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- HC Wainwright Adjusts Price Target on Genmab to $46 From $51, Maintains Buy Rating